Average Co-Inventor Count = 8.64
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (4 from 2,405 patents)
2. Takeda Pharmaceutical Company Limited (4 from 1,179 patents)
3. Metabasis Therapeutics, Inc. (3 from 64 patents)
4. Solent Therapeutics, LLC (1 from 1 patent)
9 patents:
1. 12247015 - 3-amino-4H-benzo[e][1,2,4]thiadiazine 1,1-dioxide derivatives as inhibitors of MRGX2
2. 9890145 - Heterocyclic compound
3. 9321757 - Heterocyclic compound
4. 9045496 - N-substituted oxazinopteridines and oxazinopteridinones
5. 8791107 - N-substituted oxazinopteridines and oxazinopteridinones
6. 8563746 - Cyclic benzimidazole derivatives useful as anti-diabetic agents
7. 8410284 - Cyclic benzimidazole derivatives useful as anti-diabetic agents
8. 8394969 - Cyclic benzimidazole derivatives useful as anti-diabetic agents
9. 8329914 - Cyclic benzimidazole derivatives useful as anti-diabetic agents